Regal Wealth Group, Inc. Hepion Pharmaceuticals, Inc. Transaction History

Regal Wealth Group, Inc.

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q1 2021 Apr 12, 2021	SELL	$1.77 - $2.98 $354 - $596	-200 Closed	0 $0
Q4 2020 Jan 22, 2021	BUY	$1.58 - $3.64 $316 - $728	200 New	200 $0

Ticker HEPA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,229,600
Market Cap $51.8M
Description
Hepion Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of drug therapy treatment for chronic liver diseases in the United States. It is involved in developing Rencofilstat, a cyclophilin inhibitor that has completed Phase 2a clinical trials to target multiple pathologic pathways involved in the progression of liver...

Get notified when there are updates to the investment portfolio of Regal Wealth Group, Inc., based on Form 13F filings with the SEC.

Stay updated on Regal Wealth Group, Inc. with notifications on news.